DCF — ST JOSEPH MEDICAL CENTER
Enterprise Value: $-1.3B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.3B
Enterprise Value
$-408.7M
PV of Cash Flows
$-894.2M
PV of Terminal Value
$-1.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $711.3M | $-83.1M | -12.0% | $-113.2M | $-102.9M |
| Year 2 | $732.6M | $-78.2M | -11.0% | $-109.3M | $-90.3M |
| Year 3 | $754.6M | $-73.0M | -10.0% | $-105.0M | $-78.9M |
| Year 4 | $777.2M | $-71.3M | -9.0% | $-104.2M | $-71.2M |
| Year 5 | $800.5M | $-71.5M | -9.0% | $-105.4M | $-65.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.3B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$690.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12179475239088286
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5